ArticleAdvances in therapy2026

Cost-Utility Analysis of Subcutaneous Methotrexate in the Treatment of Patients with Rheumatoid Arthritis in the UK.

Matthew Tucker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.